EAGLE PHARMACEUTICALS INC's ticker is EGRX and the CUSIP is 269796108. A total of 170 filers reported holding EAGLE PHARMACEUTICALS INC in Q4 2017. The put-call ratio across all filers is 0.73 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2017 | $298,000 | -46.0% | 5,000 | -28.6% | 0.02% | -48.3% |
| Q2 2017 | $552,000 | -5.0% | 7,000 | 0.0% | 0.03% | -6.5% |
| Q1 2017 | $581,000 | +4.7% | 7,000 | 0.0% | 0.03% | 0.0% |
| Q4 2016 | $555,000 | +13.3% | 7,000 | 0.0% | 0.03% | +14.8% |
| Q3 2016 | $490,000 | +80.1% | 7,000 | 0.0% | 0.03% | +68.8% |
| Q2 2016 | $272,000 | -4.2% | 7,000 | 0.0% | 0.02% | 0.0% |
| Q1 2016 | $284,000 | -54.3% | 7,000 | 0.0% | 0.02% | -51.5% |
| Q4 2015 | $621,000 | +67.8% | 7,000 | +40.0% | 0.03% | +65.0% |
| Q3 2015 | $370,000 | +14.6% | 5,000 | +25.0% | 0.02% | +17.6% |
| Q2 2015 | $323,000 | – | 4,000 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Krensavage Asset Management, LLC | 112,666 | $1,777 | 0.65% |
| Smith, Graham & Co., Investment Advisors, LP | 273,099 | $4,306,771 | 0.54% |
| BRANDES INVESTMENT PARTNERS, LP | 1,134,363 | $17,888,904 | 0.35% |
| TANG CAPITAL MANAGEMENT LLC | 118,857 | $1,874,375 | 0.26% |
| Virtus Investment Advisers, Inc. | 20,867 | $329,073 | 0.22% |
| DENALI ADVISORS LLC | 32,300 | $509,371 | 0.18% |
| Nebula Research & Development LLC | 11,473 | $180,929 | 0.10% |
| SCOUT INVESTMENTS, INC. | 131,192 | $1,995,430 | 0.05% |
| XTX Topco Ltd | 15,050 | $237,339 | 0.04% |
| PDT Partners, LLC | 19,745 | $311,379 | 0.04% |